Dolby Laboratories (DLB) FY2017 results: revenue $1.1 billion, up 5.4% on the year
Dolby Laboratories, Inc. (DLB) reported revenue of $1.1 billion for fiscal 2017, the year ended 29 September 2017, up 5.4% on the year before. Net income was $206 million, up 11.1%, and diluted earnings per share $2.00. The figures are the company's own, from the 10-K it filed with the SEC on 16 November 2017.
Revenue
$1.1 billion
+5.4% on the year
FY2010FY2017
Operating margin
22.9%
22.6% a year earlier
FY2010FY2017
Net income
$206 million
+11.1% on the year
FY2010FY2017
Diluted EPS
$2.00
+10.5% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
1,081
1,026
971
+5.4%
Cost of revenue
118
109
94.8
+8.6%
Gross profit
963
917
876
+5.1%
Gross margin
89.1%
89.4%
90.2%
Research and development
233
220
201
+6.2%
Operating income
247
232
213
+6.6%
Operating margin
22.9%
22.6%
22.0%
Interest expense
0.1
0.1
0.2
+1.6%
Pre-tax income
255
236
246
+8.2%
Income tax
48.0
49.5
62.5
-3.0%
Effective tax rate
18.8%
21.0%
25.4%
Net income
206
186
181
+11.1%
Net margin
19.1%
18.1%
18.7%
Diluted EPS
$2.00
$1.81
$1.75
+10.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
378
360
309
+4.9%
Capital expenditure
99.6
101
158
-1.1%
Free cash flow
278
259
152
+7.3%
Free cash flow margin
25.7%
25.3%
15.6%
Cash from investing
-158
-282
-204
Cash from financing
-107
-92.0
-139
Depreciation and amortisation
84.3
85.2
69.1
-1.0%
Share-based compensation
65.3
67.0
67.1
-2.5%
Buybacks
100
101
107
-0.8%
Dividends paid
57.1
48.4
41.0
+17.9%
Dividend per share
$0.58
$0.50
$0.42
+16.0%
Diluted shares, weighted
103m
102m
104m
+0.8%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
2,137
1,970
1,807
+8.4%
Non-controlling interest
7.1
8.5
8.9
-16.3%
Debt
0.0
0.0
0.0
Other liabilities
390
331
317
+17.6%
Total liabilities and equity
2,534
2,310
2,133
+9.7%
Fixed assets
485
444
403
+9.4%
Goodwill
311
310
308
+0.5%
Intangible assets
190
215
128
-11.9%
Investments
562
516
460
+9.0%
Cash and equivalents
634
520
532
+22.1%
Receivables
73.8
75.7
102
-2.6%
Inventory
25.1
16.4
13.9
+53.2%
Other assets
252
214
188
+17.8%
Total assets
2,534
2,310
2,133
+9.7%
10-K for the year ended 29 September 2017, filed 16 November 2017: the filing.